Metabolomics vs Illness Medicine: Why It Matters (ft. Dr. Ted Achacoso) | SNH Podcast #65

In this episode of the Smarter Not Harder Podcast, Dr. Ted Achacoso, a pioneer in Health Optimization Medicine and Practice (HOMe/HOPe), dives into the revolutionary perspective of health as an active, ongoing process rather than simply the absence of disease.

*Join us as we delve into:* + The Cell Danger Response (CDR): How it drives our body's reactions to stress, both internal and external. + Multi-omics approaches: The tools (like clinical metabolomics) that uncover imbalances before major diseases manifest. + Evolutionary medicine: Understanding our health needs in the modern world based on how our bodies evolved. + The importance of balance: Fine-tuning nutrition, inflammation, and other key systems for true health, not just feeling "not sick"

This episode is for you if: - You're interested in proactive approaches to health and longevity. - You want to understand the cutting-edge science behind optimizing your well-being. - You're frustrated with traditional medical approaches that focus solely on treating symptoms. - You're curious about how your environment, diet, and even mindset influence your health at the cellular level.

🚀 Don't miss out on this opportunity to gain valuable knowledge and take actionable steps towards a smarter, healthier lifestyle! Hit play now and join us on this enlightening journey!

*You can also find this episode on…* Youtube: https://youtu.be/ymvwCsC_Eo0

*Find more from Dr. Ted Achacoso:* Facebook: facebook.com/drtedachacoso/ Instagram: instagram.com/tedace/

*Learn more about Smarter Not Harder:* Website: https://troscriptions.com/blogs/podcast | https://homehope.org Instagram: @troscriptions | @homehopeorg

Get 10% Off your purchase of the Metabolomics Module by using PODCAST10 at https://www.homehope.org Get 10% Off your Troscriptions purchase by using POD10 at https://www.troscriptions.com Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram.